Life Sciences Wayne Samuels, partner at PwC Canada, discusses the most pressing issues in the country’s healthcare system and pharmaceutical industry, and outlines the changing dynamics in Canada’s pharma business model. What have been some of the key developments in life sciences during your tenure at PwC Canada so far? The most…
Bioscience The CEO of OBIO discusses Ontario’s challenges and opportunities in life sciences, highlighting some of the key initiatives that the organization is taking to help local companies bridge the gap between research and commercialization. What was your main objective in founding OBIO back in 2009? The main motivation for founding…
Brunel Warren Shapiro, manager of the North American division of Brunel’s life science sector, offers his insights into Canada’s immense human resources capabilities as well as Brunel’s footprint for contract labor in Canada’s life sciences industry in comparison to other worldwide regions. You have covered jurisdictions in Canada, US and Latin…
Ernst & Young LLP Mario Piccinin and Lara Iob of EY Canada discuss some of the key trends of the country’s biotech industry and the affiliate’s dedication to helping clients navigate the SR&ED tax credit process available in Canada. What do you see as the biggest challenges of life sciences clients in…
Agro-Food President of Biotalent Canada discusses the advantages of being wholly aligned with the government, why the BioTalent is a necessary link between talent and company, and what this means for the bio-economy of Canada. What was your initial mission two years ago upon arriving at Biotalent Canada, having previously worked…
Cardiology The president & CEO of CQDM discusses her vision of how CQDM’s activities can have a direct impact on the development of safer and more efficient drugs, and how to bring CQDM to a more globally competitive level. You were appointed as CEO of CQDM about ten months ago. What…
Sweden Anders Blanck of Lif Sweden discusses the Swedish healthcare system, why it’s contributing to the plunging profit margins in the pharma market, and the Swedish government’s heavy emphasis on cost-effectiveness. Technically we have 21 different healthcare systems in our country, and they all have their own political bodies, run…
Industrial Biotech Prior to joining Life Sciences Ontario (LSO), you served as CEO of GSK Canada for a number of years. What opportunities did you see in making the switch from an MNC to an association? Having been in the pharmaceutical business for my entire career in Canada, I have always been…
ProMetic Life Sciences Inc. Mr. Pierre Laurin is a senior executive with 28 years of experience in the pharmaceutical and biotechnology industry. Involved in the development of ProMetic’s platform technology since 1989, Mr. Laurin founded ProMetic Life Sciences Inc. in 1994. As Chairman until March, 2011 and President and CEO of the Corporation since…
Life Technologies Corporation The merger with Invitrogen-Applied Biosystems in 2008 was a big milestone for the company. As one of the leaders of this integration, can you please explain how this merger helped transform Life Technologies into the company it is today? The merger had an impact both internally and externally. Regarding the…
Life Technologies Corporation In the past two years Life Technologies has been investing in Singapore— last year you opened a regional distribution center in Singapore’s Tuas Biomedical Park and this June you established a Global Instrument Center of Excellence. What are the aims of both and how will they fit into the global…
Business & Decision Life Sciences Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that. Could you highlight the reasons why a special business unit dedicated to the life sciences industry needed to be created back in 2007? Founded in 1992, Business & Decisions…
See our Cookie Privacy Policy Here
